Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 18 Feb 22 424B3 Prospectus supplement
- 10 Jan 22 424B3 Prospectus supplement
- 15 Oct 21 EFFECT Notice of effectiveness
- 14 Oct 21 424B3 Prospectus supplement
-
7 Oct 21 F-1/A Registration statement (foreign) (amended)
- 14 Sep 21 F-1 Registration statement (foreign)
LBPSW similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use in this Amendment No. 1 to the Registration Statement (No. 333-259501) on Form F-1 of 4D pharma plc of our report dated April 1, 2021, relating to the consolidated financial statements of 4D pharma plc, appearing in the Prospectus, which is part of this Registration Statement.
We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ RSM US LLP
Boston, Massachusetts
October 6, 2021